Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing for 125141101 since 12/18/2024, newest first.
| Filer | % of Class | Filed | |
|---|---|---|---|
| T. Rowe Price Investment Management, Inc. 13G/A Amendment 1 | 3.7% |
8/14/2026
Event 6/30/2026
|
|
|
American Century Investment Management, Inc.
13G/A
Amendment 1
|
3.6% |
8/14/2026
Event 6/30/2026
|
|
| American Century Investment Management, Inc. | 3.6% | ||
| American Century Companies, Inc. | 3.6% | ||
| Stowers Institute for Medical Research | 3.6% | ||
|
FMR LLC
13G/A
Amendment 2
|
7.7% |
8/6/2026
Event 6/30/2026
|
|
| FMR LLC | 7.7% | ||
| Abigail P. Johnson | 7.7% | ||
| T. Rowe Price Investment Management, Inc. 13G | 6.0% |
5/15/2026
Event 3/31/2026
|
|
|
Jason DeZwirek
13D/A
Amendment 18
|
11.7% |
2/26/2026
Event 2/23/2026
|
|
| Jason DeZwirek | 11.7% | ||
| Icarus Investment Corp. | 7.8% | ||
| 0to100 Inc. | 0.6% | ||
|
American Century Investment Management, Inc.
13G
|
5.7% |
2/13/2026
Event 12/31/2025
|
|
| American Century Investment Management, Inc. | 5.7% | ||
| American Century Companies, Inc. | 5.7% | ||
| Stowers Institute for Medical Research | 5.7% | ||
| Vanguard Group Inc 13G/A Amendment 1 | 4.99% |
1/30/2026
Event 12/31/2025
|
|
| Hood River Capital Management LLC 13G/A Amendment 1 | 1.4% |
11/14/2025
Event 9/30/2025
|
|
| Capital International Investors 13G/A Amendment 1 | 4.7% |
11/13/2025
Event 9/30/2025
|
|
| Vanguard Group Inc 13G | 5.0% |
10/30/2025
Event 9/30/2025
|
|
|
FMR LLC
13G/A
Amendment 1
|
6.2% |
8/6/2025
Event 6/30/2025
|
|
| FMR LLC | 6.2% | ||
| Abigail P. Johnson | 6.2% | ||
| BlackRock, Inc. 13G/A Amendment 1 | 6.3% |
7/16/2025
Event 6/30/2025
|
|
| Hood River Capital Management LLC 13G | 5.5% |
5/15/2025
Event 3/31/2025
|
|
| Dimensional Fund Advisors LP 13G/A Amendment 8 | 3.6% |
4/15/2025
Event 3/31/2025
|
|
|
FMR LLC
13G
|
5.1% |
2/12/2025
Event 12/31/2024
|
|
| FMR LLC | 5.1% | ||
| Abigail P. Johnson | 5.1% |
| Period | Filings | Shares, Excl. Options | Value, Excl. Options |
|---|---|---|---|
| 2026 Q3 | 22 | 155 k | $8.70 M |
| 2026 Q2 | 359 | 57.7 M | $4.79 B |
| 2026 Q1 | 274 | 31.6 M | $1.88 B |
| 2025 Q4 | 238 | 29.5 M | $1.77 B |
| 2025 Q3 | 234 | 28.7 M | $1.47 B |
| 2025 Q2 | 190 | 29.6 M | $837 M |
| 2025 Q1 | 178 | 29.7 M | $678 M |
| 2024 Q4 | 180 | 28.7 M | $870 M |
| 2024 Q3 | 181 | 26.6 M | $750 M |
| 2024 Q2 | 185 | 26.2 M | $756 M |
| 2024 Q1 | 185 | 24.7 M | $568 M |
| 2023 Q4 | 167 | 24.4 M | $496 M |
| 2023 Q3 | 156 | 23.9 M | $373 M |
| 2023 Q2 | 151 | 23.9 M | $319 M |
| 2023 Q1 | 147 | 22.0 M | $308 M |
| 2022 Q4 | 126 | 22.0 M | $257 M |
| 2022 Q3 | 116 | 22.3 M | $197 M |
| 2022 Q2 | 100 | 21.9 M | $131 M |
| 2022 Q1 | 95 | 23.6 M | $129 M |
| 2021 Q4 | 91 | 23.1 M | $144 M |
| 2021 Q3 | 84 | 23.1 M | $163 M |
| 2021 Q2 | 95 | 24.1 M | $172 M |
| 2021 Q1 | 99 | 24.2 M | $192 M |
| 2020 Q4 | 90 | 27.2 M | $189 M |
| 2020 Q3 | 91 | 25.0 M | $182 M |
| 2020 Q2 | 90 | 25.0 M | $165 M |
| 2020 Q1 | 94 | 24.5 M | $114 M |
| 2019 Q4 | 110 | 25.5 M | $195 M |
| 2019 Q3 | 116 | 25.2 M | $176 M |
| 2019 Q2 | 119 | 24.4 M | $234 M |
| 2019 Q1 | 122 | 24.0 M | $172 M |
| 2018 Q4 | 115 | 24.2 M | $163 M |
| 2018 Q3 | 99 | 23.2 M | $183 M |
| 2018 Q2 | 98 | 23.4 M | $144 M |
| 2018 Q1 | 103 | 23.3 M | $104 M |
| 2017 Q4 | 109 | 23.0 M | $118 M |
| 2017 Q3 | 117 | 23.4 M | $198 M |
| 2017 Q2 | 132 | 23.5 M | $216 M |
| 2017 Q1 | 149 | 24.3 M | $255 M |
| 2016 Q4 | 136 | 21.6 M | $302 M |
| 2016 Q3 | 117 | 19.1 M | $216 M |
| 2016 Q2 | 100 | 18.4 M | $161 M |
| 2016 Q1 | 104 | 18.5 M | $115 M |
| 2015 Q4 | 107 | 18.5 M | $142 M |
| 2015 Q3 | 118 | 18.4 M | $151 M |
| 2015 Q2 | 97 | 13.0 M | $146 M |
| 2015 Q1 | 91 | 13.5 M | $144 M |
| 2014 Q4 | 101 | 13.7 M | $213 M |
| 2014 Q3 | 101 | 13.1 M | $176 M |
| 2014 Q2 | 108 | 13.0 M | $203 M |
| 2014 Q1 | 103 | 12.3 M | $205 M |